| 000 | 01510 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515173518.0 | ||
| 264 | 0 | _c20090814 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1173-2563 | ||
| 024 | 7 |
_a10.2165/00044011-200929070-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChu, Nan-Nan | |
| 245 | 0 | 0 |
_aPharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study. _h[electronic resource] |
| 260 |
_bClinical drug investigation _c2009 |
||
| 300 |
_a451-457 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacokinetics |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 |
_aDibenzoxepins _xpharmacokinetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOlopatadine Hydrochloride |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChen, Wei-Li | |
| 700 | 1 | _aXu, Hong-Rong | |
| 700 | 1 | _aLi, Xue-Ning | |
| 773 | 0 |
_tClinical drug investigation _gvol. 29 _gno. 7 _gp. 451-457 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00044011-200929070-00003 _zAvailable from publisher's website |
| 999 |
_c18923882 _d18923882 |
||